Enteral Access Technologies develops medical devices for safer nasogastric tube placement, featuring DoubleCHEK.
Enteral Access Technologies has raised $659K in total funding. The most recent round was Seed. The last funding was announced in November 2025.
Enteral Access Technologies's investors include The Future Fund, British Design Fund.
Enteral Access Technologies is headquartered in Liverpool, United Kingdom.
Enteral Access Technologies develops medical devices for safer nasogastric tube placement, featuring DoubleCHEK.
Enteral Access Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enteral Access Technologies — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/enteral-access-technologies. Accessed October 30, 2026.
VCBacked. (2025). Enteral Access Technologies — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/enteral-access-technologies
{{cite web |title=Enteral Access Technologies — Funding & Investors |url=https://www.vcbacked.co/company/enteral-access-technologies |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated